Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Advances in Experimental Medicine and Biology
|
July 17, 1998
Cannabinoid receptor agonists enhance syncytia formation in MT-2 cells infected with cell free HIV-1MN
S N Noe, S B Nyland, K Ugen, et al.
Current Topics in Microbiology and Immunology
|
February 28, 1998
DNA plasmid based vaccination against the oncogenic human T cell leukemia virus type 1
M G Agadjanyan, B Wang, S B Nyland, et al.
Leukemia Research Reports
|
February 25, 2015
Emergence of a STAT3 mutated NK clone in LGL leukemia
Yiyi Yan, Thomas L Olson, Susan B Nyland, et al.
International Journal of Oncology
|
January 13, 2005
Constitutive production of proinflammatory cytokines RANTES, MIP-1beta and IL-18 characterizes LGL leukemia
Ravi Kothapalli, Susan B Nyland, Irina Kusmartseva, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 15, 2008
Network model of survival signaling in large granular lymphocyte leukemia
Ranran Zhang, Mithun Vinod Shah, Jun Yang, et al.
British Journal of Haematology
|
October 15, 2019
Retroviral sero-reactivity in LGL leukaemia patients and family members
Susan B Nyland, David J Feith, Mary Poss, et al.
Blood
|
November 3, 2009
Platelet-derived growth factor mediates survival of leukemic large granular lymphocytes via an autocrine regulatory pathway
Jun Yang, Xin Liu, Susan B Nyland, et al.
Vaccine
|
October 31, 1998
DNA vaccination with HIV-1 expressing constructs elicits immune responses in humans
K E Ugen, S B Nyland, J D Boyer, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Advances in Experimental Medicine and Biology
|
July 17, 1998
Cannabinoid receptor agonists enhance syncytia formation in MT-2 cells infected with cell free HIV-1MN
S N Noe, S B Nyland, K Ugen, et al.
Current Topics in Microbiology and Immunology
|
February 28, 1998
DNA plasmid based vaccination against the oncogenic human T cell leukemia virus type 1
M G Agadjanyan, B Wang, S B Nyland, et al.
Leukemia Research Reports
|
February 25, 2015
Emergence of a STAT3 mutated NK clone in LGL leukemia
Yiyi Yan, Thomas L Olson, Susan B Nyland, et al.
International Journal of Oncology
|
January 13, 2005
Constitutive production of proinflammatory cytokines RANTES, MIP-1beta and IL-18 characterizes LGL leukemia
Ravi Kothapalli, Susan B Nyland, Irina Kusmartseva, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 15, 2008
Network model of survival signaling in large granular lymphocyte leukemia
Ranran Zhang, Mithun Vinod Shah, Jun Yang, et al.
British Journal of Haematology
|
October 15, 2019
Retroviral sero-reactivity in LGL leukaemia patients and family members
Susan B Nyland, David J Feith, Mary Poss, et al.
Blood
|
November 3, 2009
Platelet-derived growth factor mediates survival of leukemic large granular lymphocytes via an autocrine regulatory pathway
Jun Yang, Xin Liu, Susan B Nyland, et al.
Vaccine
|
October 31, 1998
DNA vaccination with HIV-1 expressing constructs elicits immune responses in humans
K E Ugen, S B Nyland, J D Boyer, et al.
Page
of 2